Eintrag weiter verarbeiten
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia
Gespeichert in:
| Zeitschriftentitel: | Blood |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , |
| In: | Blood, 125, 2015, 19, S. 2915-2922 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society of Hematology
|
| Schlagwörter: |
| author_facet |
Brown, Jennifer R. Barrientos, Jacqueline C. Barr, Paul M. Flinn, Ian W. Burger, Jan A. Tran, Anh Clow, Fong James, Danelle F. Graef, Thorsten Friedberg, Jonathan W. Rai, Kanti O’Brien, Susan Brown, Jennifer R. Barrientos, Jacqueline C. Barr, Paul M. Flinn, Ian W. Burger, Jan A. Tran, Anh Clow, Fong James, Danelle F. Graef, Thorsten Friedberg, Jonathan W. Rai, Kanti O’Brien, Susan |
|---|---|
| author |
Brown, Jennifer R. Barrientos, Jacqueline C. Barr, Paul M. Flinn, Ian W. Burger, Jan A. Tran, Anh Clow, Fong James, Danelle F. Graef, Thorsten Friedberg, Jonathan W. Rai, Kanti O’Brien, Susan |
| spellingShingle |
Brown, Jennifer R. Barrientos, Jacqueline C. Barr, Paul M. Flinn, Ian W. Burger, Jan A. Tran, Anh Clow, Fong James, Danelle F. Graef, Thorsten Friedberg, Jonathan W. Rai, Kanti O’Brien, Susan Blood The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia Cell Biology Hematology Immunology Biochemistry |
| author_sort |
brown, jennifer r. |
| spelling |
Brown, Jennifer R. Barrientos, Jacqueline C. Barr, Paul M. Flinn, Ian W. Burger, Jan A. Tran, Anh Clow, Fong James, Danelle F. Graef, Thorsten Friedberg, Jonathan W. Rai, Kanti O’Brien, Susan 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2014-09-585869 <jats:title>Key Points</jats:title> <jats:p>Ibrutinib was well tolerated when administered with BR CIT in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma. Ibrutinib added to CIT was associated with a high degree of clinical activity that compares favorably to historical reports of CIT alone.</jats:p> The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia Blood |
| doi_str_mv |
10.1182/blood-2014-09-585869 |
| facet_avail |
Online Free |
| finc_class_facet |
Biologie Medizin Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE0LTA5LTU4NTg2OQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE0LTA5LTU4NTg2OQ |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
American Society of Hematology, 2015 |
| imprint_str_mv |
American Society of Hematology, 2015 |
| issn |
0006-4971 1528-0020 |
| issn_str_mv |
0006-4971 1528-0020 |
| language |
English |
| mega_collection |
American Society of Hematology (CrossRef) |
| match_str |
brown2015thebrutontyrosinekinaseinhibitoribrutinibwithchemoimmunotherapyinpatientswithchroniclymphocyticleukemia |
| publishDateSort |
2015 |
| publisher |
American Society of Hematology |
| recordtype |
ai |
| record_format |
ai |
| series |
Blood |
| source_id |
49 |
| title |
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_unstemmed |
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_full |
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_fullStr |
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_full_unstemmed |
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_short |
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_sort |
the bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| topic |
Cell Biology Hematology Immunology Biochemistry |
| url |
http://dx.doi.org/10.1182/blood-2014-09-585869 |
| publishDate |
2015 |
| physical |
2915-2922 |
| description |
<jats:title>Key Points</jats:title>
<jats:p>Ibrutinib was well tolerated when administered with BR CIT in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma. Ibrutinib added to CIT was associated with a high degree of clinical activity that compares favorably to historical reports of CIT alone.</jats:p> |
| container_issue |
19 |
| container_start_page |
2915 |
| container_title |
Blood |
| container_volume |
125 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792334818797682696 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:34:42.354Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+Bruton+tyrosine+kinase+inhibitor+ibrutinib+with+chemoimmunotherapy+in+patients+with+chronic+lymphocytic+leukemia&rft.date=2015-05-07&genre=article&issn=1528-0020&volume=125&issue=19&spage=2915&epage=2922&pages=2915-2922&jtitle=Blood&atitle=The+Bruton+tyrosine+kinase+inhibitor+ibrutinib+with+chemoimmunotherapy+in+patients+with+chronic+lymphocytic+leukemia&aulast=O%E2%80%99Brien&aufirst=Susan&rft_id=info%3Adoi%2F10.1182%2Fblood-2014-09-585869&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792334818797682696 |
| author | Brown, Jennifer R., Barrientos, Jacqueline C., Barr, Paul M., Flinn, Ian W., Burger, Jan A., Tran, Anh, Clow, Fong, James, Danelle F., Graef, Thorsten, Friedberg, Jonathan W., Rai, Kanti, O’Brien, Susan |
| author_facet | Brown, Jennifer R., Barrientos, Jacqueline C., Barr, Paul M., Flinn, Ian W., Burger, Jan A., Tran, Anh, Clow, Fong, James, Danelle F., Graef, Thorsten, Friedberg, Jonathan W., Rai, Kanti, O’Brien, Susan, Brown, Jennifer R., Barrientos, Jacqueline C., Barr, Paul M., Flinn, Ian W., Burger, Jan A., Tran, Anh, Clow, Fong, James, Danelle F., Graef, Thorsten, Friedberg, Jonathan W., Rai, Kanti, O’Brien, Susan |
| author_sort | brown, jennifer r. |
| container_issue | 19 |
| container_start_page | 2915 |
| container_title | Blood |
| container_volume | 125 |
| description | <jats:title>Key Points</jats:title> <jats:p>Ibrutinib was well tolerated when administered with BR CIT in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma. Ibrutinib added to CIT was associated with a high degree of clinical activity that compares favorably to historical reports of CIT alone.</jats:p> |
| doi_str_mv | 10.1182/blood-2014-09-585869 |
| facet_avail | Online, Free |
| finc_class_facet | Biologie, Medizin, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE0LTA5LTU4NTg2OQ |
| imprint | American Society of Hematology, 2015 |
| imprint_str_mv | American Society of Hematology, 2015 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 0006-4971, 1528-0020 |
| issn_str_mv | 0006-4971, 1528-0020 |
| language | English |
| last_indexed | 2024-03-01T14:34:42.354Z |
| match_str | brown2015thebrutontyrosinekinaseinhibitoribrutinibwithchemoimmunotherapyinpatientswithchroniclymphocyticleukemia |
| mega_collection | American Society of Hematology (CrossRef) |
| physical | 2915-2922 |
| publishDate | 2015 |
| publishDateSort | 2015 |
| publisher | American Society of Hematology |
| record_format | ai |
| recordtype | ai |
| series | Blood |
| source_id | 49 |
| spelling | Brown, Jennifer R. Barrientos, Jacqueline C. Barr, Paul M. Flinn, Ian W. Burger, Jan A. Tran, Anh Clow, Fong James, Danelle F. Graef, Thorsten Friedberg, Jonathan W. Rai, Kanti O’Brien, Susan 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2014-09-585869 <jats:title>Key Points</jats:title> <jats:p>Ibrutinib was well tolerated when administered with BR CIT in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma. Ibrutinib added to CIT was associated with a high degree of clinical activity that compares favorably to historical reports of CIT alone.</jats:p> The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia Blood |
| spellingShingle | Brown, Jennifer R., Barrientos, Jacqueline C., Barr, Paul M., Flinn, Ian W., Burger, Jan A., Tran, Anh, Clow, Fong, James, Danelle F., Graef, Thorsten, Friedberg, Jonathan W., Rai, Kanti, O’Brien, Susan, Blood, The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia, Cell Biology, Hematology, Immunology, Biochemistry |
| title | The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_full | The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_fullStr | The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_full_unstemmed | The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_short | The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_sort | the bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| title_unstemmed | The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia |
| topic | Cell Biology, Hematology, Immunology, Biochemistry |
| url | http://dx.doi.org/10.1182/blood-2014-09-585869 |